VVOSVivos Therapeutics, Inc.
0.6750USD-0.01%Mkt Cap: 9.37M USDP/E: Last update: 2026-06-01

Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), …

Indicators:|

Key Statistics

Company
Market Cap9.37M USD
Enterprise Value19.76M USD
Revenue (TTM)19.57M USD
Gross Profit10.54M USD
Net Income (TTM)-21.23M USD
Revenue/Share1.661 USD
Last Price0.6750 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees268
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-2.00
PEG
EV/EBITDA-0.94
EV/Revenue1.01
P/S0.50
P/B2.29
EPS (TTM)-2.14
EPS (Forward)-0.35
52W Range
0.54502% of range7.950
52W High7.950 USD
52W Low0.5450 USD
Profitability
Gross Margin60.44%
Oper. Margin-128.67%
EBITDA Margin-107.34%
Profit Margin-121.71%
ROE1424.83%
ROA-84.41%
Growth
Revenue Growth70.50%
Earnings Growth
Cash Flow & Leverage
Operating CF-15.26M USD
CapEx (TTM)2.34M USD
FCF Margin-51.49%
FCF Yield-107.50%
Net Debt10.16M USD
Net Debt/EBITDA-0.48
Balance Sheet
Debt/Equity-9.06
Current Ratio0.27
Quick Ratio0.22
Book Value/Sh0.3060 USD
Cash/Share0.1520 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:25
Split DateOct 27, 2023
Analyst Consensus
Rating1.7 (Buy)
Target (Mean)2.417 USD
Target Range1.750 USD3.000 USD
# Analysts3
Ownership
Shares Out.13.89M
Float12.05M
Insiders25.72%
Institutions14.07%
Short Interest
Short Ratio3.8d
Short % Float8.94%
Short % Out.7.13%
Shares Short978.07K
Short (prev mo.)554.02K
Technical
SMA 500.9390 (-28.1%)
SMA 2002.132 (-68.3%)
Beta6.21
S&P 52W Chg27.70%
Avg Vol (30d)182.05K
Avg Vol (10d)159.57K
Technical Indicators
RSI (14)40.7
MACD-0.0859
MACD Signal-0.1085
MACD Hist.+0.0226
BB Upper0.7873 USD
BB Middle0.6696 USD
BB Lower0.5518 USD
BB Width35.18%
ATR (14)0.0772 USD
Vol Ratio (20d)0.21x